|
Model Number 0052-3021 |
Device Problems
Break (1069); Crack (1135)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/03/2022 |
Event Type
Injury
|
Event Description
|
Patient was presented with right ventricular failure.The procedure was for femoral vein insertion for placement of the impella rp (rp).First attempted impella rp insertion from the left femoral vein and the 23 fr sheath kinked.The kink occurred because of the tortuosity of the iliac artery.Then went to the right femoral vein with a new sheath.X-ray showed sheath was kinked as well, but were able to pass the rp through it.It is uncertain as to why it split, it was a straight shot and no issues were observed.Rather than rewire and attempt re-seat the rp, the physician elected to pull the rp, put large dilator in, and pulled the split sheath without complication.When the sheath split and the rp was not placed, they went to the or for placement of other support devices.It is believed the patient was then sent to surgery for centrimag/protek duo.Patient outcome was reported as no harm.No additional information available.
|
|
Manufacturer Narrative
|
Conclusion not yet available, evaluation in process.A follow-up will be submitted as soon as the investigation is complete.
|
|
Manufacturer Narrative
|
Correction h1: serious injury.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|
|
Manufacturer Narrative
|
The device was used for treatment.The device was not returned for evaluation, as a result, the exact cause of the product issue cannot be determined and the clinical observation could not be confirmed.However, the following controls are in place to mitigate the reported product issue.The device history records were reviewed to confirm that the device passed all applicable in-process and final inspections before shipping to the customer.Per abiomed introducer sheath in-process and final inspections procedure: 9.2.1:b measure dimensions: measure tip i.D.Of sheath using appropriate pin gauges to be in range of 0.305" - 0.307" for 23f.9.2.2 visual inspection: using 10x magnification, verify the tip is round, no flash protruding greater than 0.4 mm (0.016") and no flash with width (around circumference) greater than 0.7 mm (0.028"), no splitting, cracks or other damages.Per section 12.2, visual inspection, with naked eye at a distance of 12" to 18", verify the assembled sheath matches the drawing.Ensure parts are free of kinks, cracks, splits, sinks, excessive flash, loose/embedded fm, or any other damages.The instructions for use (ifu) informs the user: never advance or withdraw guidewire or sheath when resistance is met.Determine cause by fluoroscopy and take remedial action.When injecting or aspirating through the sheath, use the sideport only.Avoid subjecting the device to unusual stresses.When assembling the sheath and dilator, care must be taken to insert the dilator tip straight through the center of the valve membrane in order to prevent inadvertent puncturing of the membrane.Abiomed provides the ifu for this product.No further follow-up is required.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|
|
Search Alerts/Recalls
|
|
|